Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats

Anesthesiology

Volumn 116, Issue 5, 2012, Pages 1057-1065

  Pejo, Ervin ^a   Ge, Rile ^a   Banacos, Natalie ^a   Cotten, Joseph F ^a,b   Husain, S Shaukat ^a,b   Raines, Douglas E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; METHOXYCARBONYL ETOMIDATE CARBOXYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; ELECTROENCEPHALOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; DEEP SEDATION; ELECTROENCEPHALOGRAPHY; ETOMIDATE; HALF-LIFE; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; KINETICS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REFLEX;

EID: 84860737916     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182515403     Document Type: Article

References (21)

1. Cotten JF, Husain SS, Forman SA, Miller KW, Kelly EW, Nguyen HH, Raines DE: Methoxycarbonyl-etomidate: A novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression. ANESTHESIOLOGY 2009; 111:240-9
2. Cotten JF, Le Ge R, Banacos N, Pejo E, Husain SS, Williams JH, Raines DE: Closed-loop continuous infusions of etomidate and etomidate analogs in rats: A comparative study of dosing and the impact on adrenocortical function. ANESTHESIOLOGY 2011; 115:764-73
3. Bodor N, Buchwald P: Soft drug design: General principles and recent applications. Med Res Rev 2000; 20:58-101
4. Ge RL, Pejo E, Haburcak M, Husain SS, Forman SA, Raines DE: Pharmacological studies of methoxycarbonyl etomidate's carboxylic acid metabolite. Anesth Analg 2011; [Epub ahead of print]
5. Eger EI 2nd, Shafer SL: Tutorial: Context-sensitive decrement times for inhaled anesthetics. Anesth Analg 2005; 101: 688-96
6. Hughes MA, Glass PS, Jacobs JR: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. ANESTHESIOLOGY 1992; 76:334-41
7. Hoke JF, Shlugman D, Dershwitz M, Michałowski P, Malthouse-Dufore S, Connors PM, Martel D, Rosow CE, Muir KT, Rubin N, Glass PS: Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. ANESTHESIOLOGY 1997; 87:533-41
8. Egan TD, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL: Remifentanil versus alfentanil: Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. ANESTHESIOLOGY 1996; 84:821-33
9. Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL: Measured context-sensitive half-times of remifentanil and alfentanil. ANESTHESIOLOGY 1995; 83: 968-75
10. Vijn PC, Sneyd JR: I.V. anaesthesia and EEG burst suppression in rats: Bolus injections and closed-loop infusions. Br J Anaesth 1998; 81:415-21
11. Rampil IJ, Laster MJ: No correlation between quantitative electroencephalographic measurements and movement response to noxious stimuli during isoflurane anesthesia in rats. ANESTHESIOLOGY 1992; 77:920-5
12. Hubbard KE, Schaiquevich P, Bai F, Fraga CH, Miller L, Panetta JC, Stewart CF: Application of a highly specific and sensitive fluorescent HPLC method for topotecan lactone in whole blood. Biomed Chromatogr 2009; 23:707-13
13. Validation of Analytical Procedures: Text and Methodology Q2(R1), International Conference of Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 1994
14. Pejo E, Cotton JF, Kelly EW, Le Ge R, Cuny GD, Laha JK, Liu J, Lin XJ, Raines DE: In vivo and in vitro pharmacological studies of methoxycarbonyl- carboetomidate. Anesth Analg 2011; [Epub ahead of print]
15. Kissin I, Mason JO 3rd, Bradley EL Jr: Pentobarbital and thiopental anesthetic interactions with midazolam. ANESTHESIOLOGY 1987; 67:26-31
16. Calvo R, Carlos R, Erill S: Etomidate and plasma esterase activity in man and experimental animals. Pharmacology 1979; 18:294-8
17. Feldman PL, James MK, Brackeen MF, Bilotta JM, Schuster SV, Lahey AP, Lutz MW, Johnson MR, Leighton HJ: Design, synthesis, and pharmacological evaluation of ultrashort-to long-acting opioid analgetics. J Med Chem 1991; 34:2202-8
18. Quon CY, Mai K, Patil G, Stampfli HF: Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab Dispos 1988; 16:425-8
19. Flaherty JF, Wong B, La Follette G, Warnock DG, Hulse JD, Gambertoglio JG: Pharmacokinetics of esmolol and ASL-8123 in renal failure. Clin Pharmacol Ther 1989; 45:321-7
20. Sneyd JR, Rigby-Jones AE: New drugs and technologies, intravenous anaesthesia is on the move (again). Br J Anaesth 2010; 105:246-54
21. Sneyd JR: Recent advances in intravenous anaesthesia. Br J Anaesth 2004; 93:725-36